Bayada is bringing in a chief executive from outside the founding family for the first time in the company's 50-year history.

This expansion supports a strategic initiative to embed Eli Lilly within emerging biotechnology ecosystems. The Gateway Labs program provides promising startups with modern laboratory space and direct ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly & Co. is bringing a pharmaceutical startup incubator to 2300 Market St. MCB Science + Health has finished the ...

Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, developed 2300 Market to be the most comprehensive R&D ecosystem in the Philadelphia market. Legend Biotech selected the ...

The pharmaceutical sector is witnessing remarkable momentum behind Eli Lilly, with the diabetes and obesity treatment specialist's stock demonstrating sustai ...

Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.

To provide access to dedicated, fully equipped wet lab facilities and strategic scientific engagement.

Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing ...

La Mancha Investments S. à r. l. (La Mancha), a wholly owned subsidiary of La Mancha Resource Fund SCSp (which is advised by La Mancha Resource Capital LLP), announces today that between ...

Data from the keynote report at the 18th Annual Conference of the Chinese Society of Reproductive Medicine (CSRM2025), held from November 12th to 15th, indicates that the average treatment age for ...

Philadelphia is joining the San Francisco Bay area, Boston, and San Diego as a host of a Lilly Gateway Labs biotech incubator ...